Aspiriant LLC’s WisdomTree Europe Hedged Equity Fund HEDJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-10,902
Closed -$340K 209
2017
Q2
$340K Buy
+10,902
New +$353K 0.03% 164
2016
Q4
Sell
-73,730
Closed -$1.98M 186
2016
Q3
$1.98M Sell
73,730
-384,314
-84% -$10.2M 0.2% 71
2016
Q2
$12.7M Buy
+458,044
New +$11.9M 1.2% 14
2014
Q4
Sell
-8,440
Closed -$244K 94
2014
Q3
$244K Sell
8,440
-13,956
-62% -$402K 0.03% 72
2014
Q2
$654K Sell
22,396
-8,580
-28% -$250K 0.09% 56
2014
Q1
$876K Buy
+30,976
New +$856K 0.13% 55

Other funds holding HEDJ

Aspiriant LLC's HEDJ Position: Q3 2017 in Review

Aspiriant LLC sold out of WisdomTree Europe Hedged Equity Fund (HEDJ) in Q3 2017, closing a stake of 10,902 shares — an estimated $340K sold.

Aspiriant LLC first reported a position in HEDJ in Q1 2014 and held it in 6 quarters. The position peaked at $12.7M in Q2 2016. 304 funds tracked by Wall St. Rank hold HEDJ as of Q3 2017.

  • Aspiriant LLC reported no remaining WisdomTree Europe Hedged Equity Fund position as of Q3 2017 after selling out during the quarter.
  • Aspiriant LLC sold 10,902 WisdomTree Europe Hedged Equity Fund shares in Q3 2017, an estimated $340K.
  • Aspiriant LLC first reported a position in WisdomTree Europe Hedged Equity Fund in Q1 2014 and held it in 6 quarters.
  • Aspiriant LLC's WisdomTree Europe Hedged Equity Fund position peaked at $12.7M in Q2 2016.
  • 304 funds tracked by Wall St. Rank held WisdomTree Europe Hedged Equity Fund as of Q3 2017.

Based on Aspiriant LLC's 13F filing for Q3 2017, filed 13 Nov 2017.